FDAnews Announces — FDA’s Guidance on Postmarket Management of Cybersecurity in Medical Devices Webinar, March 24, 2017

Share Article

With significant technological advances in patient care comes the increased risk of cybersecurity breaches that could affect a device’s performance and functionality. Join Nick Sikorski and Jongbum Keum — both of Deloitte & Touche LLP, Life Sciences & Healthcare Sector – Cyber Risk Services — on March 24 when they’ll discuss the final guidance on postmarket management of cybersecurity in medical devices which was released in Dec. 2016.

FDAnews

FDAnews

FDA’s Guidance on Postmarket Management
of Cybersecurity in Medical Devices
**An FDAnews Webinar**
March 24, 2017 — 1:30 p.m. – 3:00 p.m. ET
http://www.fdanews.com/postmarketmd        

When should manufacturers deploy software patches to address cybersecurity issues?

Has a process for working with cybersecurity researchers and other stakeholders to receive information about potential vulnerabilities been established?

With significant technological advances in patient care comes the increased risk of cybersecurity breaches that could affect a device’s performance and functionality.

Join Nick Sikorski and Jongbum Keum — both of Deloitte & Touche LLP, Life Sciences & Healthcare Sector – Cyber Risk Services — on March 24 when they’ll discuss the final guidance on postmarket management of cybersecurity in medical devices which was released in Dec. 2016.

After this 90-minute webinar attendees will know:

  •     What the FDA’s recommendations are for managing postmarket cybersecurity vulnerabilities
  •     What manufacturers should monitor, identify, and address cybersecurity vulnerabilities and exploits as part of their postmarket management of medical devices
  •     How to establish a risk-based framework for assessing when changes to medical devices for cybersecurity vulnerabilities require reporting to the FDA
  •     Techniques for outlining circumstances in which the FDA does not intend to enforce reporting requirements under 21 CFR, part 806

Register today and get up-to-speed on what the new cybersecurity final guidance means for the industry.

Who Will Benefit:

  •     QA/QC personnel
  •     Data management and statistics personnel
  •     Engineering and design controls teams
  •     Risk management specialists
  •     Compliance officers

Webinar Details:
FDA’s Guidance on Postmarket Management
of Cybersecurity in Medical Devices
**An FDAnews Webinar**
March 24, 2017 — 1:30 p.m. – 3:00 p.m. ET
http://www.fdanews.com/postmarketmd            

Tuition:
$287 per site

Easy Ways to Register:
Online:     http://www.fdanews.com/postmarketmd                                        
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website